Invention Grant
![2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same](/docs/US/2021-04-06/US10968167B2/abs.jpg.600x600.jpg)
- Patent Title: 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same
-
Application No.: US16975054Application Date: 2019-02-20
-
Publication No.: US10968167B2Publication Date: 2021-04-06
- Inventor: Michael O'Neill , Barbara Kidon , William A. Janz , Hongqiao Wu
- Applicant: Abrexa Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Abrexa Pharmaceuticals, Inc.
- Current Assignee: Abrexa Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Pillsbury Winthrop Shaw Pittman, LLP
- International Application: PCT/US2019/018835 WO 20190220
- International Announcement: WO2019/164997 WO 20190829
- Main IPC: C07C249/16
- IPC: C07C249/16
![2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same](/abs-image/US/2021/04/06/US10968167B2/abs.jpg.150x150.jpg)
Abstract:
Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.
Information query
